Complete profile


Third-Party Information Liability Disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.




Last Updated: 2012-06-28

Scimega Research Inc.

Company information

Logo  
 
Legal Name:   Scimega Research Inc.
Operating Name:   Scimega Research Inc.
 
Mailing Address
336-5764 De Monkland Ave
MONTRÉAL, Quebec
H4A 1E9
Location Address
4423 D'Oxford Ave
MONTRÉAL, Quebec
H4A 2Y7
 
Telephone: (450) 629-2200
Ext: 225
Fax: (450) 629-7879
Email: info@scimega.com
Website URL: http://www.scimega.com 
 
Top

Contact information

 
Denise Deakin
  Title:   President
  Area of Responsibility:   Management Executive
  Telephone:   (450) 629-2200
  Ext:   225
  Fax:   (450) 629-7879
  Email:   ddeakin@scimega.com
 
 
Roberto Lara
  Title:   Director
  Area of Responsibility:   Domestic Sales & Marketing
  Telephone:   (450) 629-2200
  Ext:   226
  Fax:   (450) 629-7879
  Email:   rlara@scimega.com
 

Top

Company description

 
Scimega Research was founded to meet the industry’s demand for superior clinical trial management services in the complex field of oncology clinical research. The fact that four of the world’s ten largest pharmaceutical companies have chosen to partner with us is a testament to the value and personalized attention we provide to all our clients. With an established reputation for exceptional quality and reliability, Scimega Research is one of the world’s most respected CROs in their field.
Successful execution of 52 oncology studies across 23 indications demonstrates our proven clinical trial management expertise. This represents only a portion of the extensive, combined career experience of our team of oncology professionals. From clinical development plan to study closure, your project is managed by clinical oncology experts qualified and committed to helping you reduce risk and realize the full potential of your product pipeline.

No other CRO can match the depth of knowledge and relationships we’ve built up within the Canadian clinical oncology research community. We are a dedicated oncology CRO with over 80-years combined experience working with novel, complex oncology studies.  
Country of Ownership: Canada  
Year Established: 1997
Exporting: Yes  
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Alternate Industries (NAICS): 541690 - Other Scientific and Technical Consulting Services
541990 - All Other Professional, Scientific and Technical Services
621510 - Medical and Diagnostic Laboratories
Primary Business Activity: Services  
Number of Employees: 13 

Top

Product / Service / Licensing

 
Service Name: Clinical Trial Services
 
Scimega Research was founded to meet the industry’s demand for superior clinical management services in the complex field of oncology clinical research. Our organization can provide full services or select services which support phase I-phase IV clinical research activities.

 
Service Name: Data management
 
Scimega Research was founded to meet the industry’s demand for superior clinical trial services in the complex field of oncology clinical research.

 
Service Name: Feasibility studies
 
Our Reverse Feasibility Program – a collaborative approach, funded by Scimega Research, bringing biotech sponsors and Canadian investigators together to facilitate recruitment and accelerate study start-up times while meeting the needs of cancer patients.

 
Service Name: Oncology clinical trial monitoring
 
The rapid collection of clean and pertinent data is your key to making strategic, well informed drug development decisions. Our highly experienced clinical research associates provide investigative teams with clear guidance and advice to simplify the study management process leading to fewer study deviations and reducing the number of overall visits. By adhering to ICH/GCP guidelines we provide peace of mind that your clinical trial will be run safely, smoothly and efficiently from site initiation to study closure.

Our research associates act as ambassadors to your organization, ensuring that your company is respected as a knowledgeable stakeholder in the field of oncology clinical trials.

 
Service Name: Patient recruitment and site selection
 
The Scimega Advantage - turns our oncology monitoring expertise into your competitive advantage.
The Reverse Feasibility Program
Finding the right investigative sites for your oncology clinical trials just got a whole lot easier. Match your protocol with the current study needs and interests of highly motivated and pre-qualified sites.

 
Service Name: Project & site management
 
From site selection to study closure, your project will be managed by qualified oncology CRO professionals committed to providing accurate, relevant and timely results within budget.

Our Strategic Project Managers share their knowledge while anticipating your needs. In accordance with clearly defined project plans and key performance indicators, the Project Manager is ultimately accountable for ensuring that each project team reaches or surpasses its objectives and that all discrepancies related to quality, budget or timelines are immediately identified and corrected.

 
Service Name: Regulatory Affairs
 
Our knowledge and expertise of the Canadian regulatory environment is your key to a successful clinical trial application (CTA) submission. We take a strategic approach by evaluating the particular regulatory situation of each dossier with regard to the available scientific data. Our regulatory affairs expert will then identify and proactively address potential questions from Health Canada to help you avoid unnecessary delays and costs related to your CTA approval.



 

Top

Market profile

Alliances:

  • Sales/Marketing

Industry sector market interests:

  • Medical/Biotechnology/Chemical

Top

Sector information

Distribution of employees

Scimega Research Inc, founded in Montreal (Canada), is a niche CRO dedicated to the successful management of Oncology Clinical Trials since 1997. Our headquarters is located in Montreal, Quebec, Canada and our staff is strategically distributed throughout Canada’s larger metropolitan cities with access to International Airports. Moreover, we have developed a network of Expert Oncology Service Providers in the USA and Europe thereby assuring our clients with continuity sophisticated services to match our standards and your expectations.

Success stories:

http://www.scimega.com/biotech-sponsors-collaborative-relationship-part1.php

One of the world's leading pharmaceutical companies chose Scimega Research as their partner in Canada for a Phase II international oncology clinical trial.

The Problem
The trial was conducted in three European countries as well as Canada. During the course of the recruitment period, it became evident that the European investigative teams would not be able to meet their targets for patient recruitment.

The Solution
To prevent further recruitment delays and associated rising costs, Canada’s recruitment target was increased. Together, the Canadian investigative teams met 161% of their Canadian patient quota, accounting for 61% of all the patients who took part in the international study.

The Results
With one of the Canadian sites earning top recruiter status for the entire clinical trial study, Scimega exceeded the sponsor's expectations in more areas than just the volume of data monitored. Whereas European sites delivered an average query rate of 15.57%, Scimega’s query rate was only 9.8%.

Considering the costs associated with correcting a query, Scimega saved the client close to $80,000 based solely on their low query rate compared to Europe. But they also provided data to the client faster so they could make key decisions as soon as possible.

78% of Scimega's queries were returned to the sponsor within 24 hours. An additional 17% followed within 3 days and the rest were delivered within 5 days. Having established a query return target of 42 days at the outset of the study, the client was understandably pleased.

Testimonial:

"FANTASTIC!!! is the first thing that comes to mind. I cannot say enough about the Scimega team who have done an amazing job meeting the targets for all sites as well as keeping us informed. It has been a very co-operative, cohesive team, which is so important. My sincere thanks to you all."
- Director of Operations, Multi-national Pharmaceutical Client

"Scimega is very thorough, reliable, easy to work with and are always available to answer questions. It was a real pleasure to work with them."
- Unit Coordinator, Jewish General Hospital Clinical Research Unit

Top



Note: This document is presented in the language provided by the author/source. Most of the information contained in Canadian Company Capabilities (CCC) has been provided by sources external to Industry Canada. The accuracy, currency and reliability of the information contained in CCC are the sole responsibility of the registered companies and related organizations. Industry Canada assumes no responsibility in this respect. The registered businesses shall ensure the continued monitoring of the information contained in CCC and ask that it be modified when necessary.